Intranet Fakultät für Chemie und Pharmazie

Dr. Sabine Schneider


Ludwig-Maximilians-Universität München
Department of Chemistry
Butenandtstr. 5-13
D-81377 Munich

Phone 77716
Room-Nr. F4.082
Home page

Research Interests

  • Structured nucleic acids
  • Structural biology
  • Molecular recognition mechanisms of nucleic acids and proteins

Short CV

  • Since 06/2019 Heisenberg fellow and Research group leader at the Department of Chemistry, Ludwig- Maximilians University, Munich, Germany
  • Since 04/2015 Co-Speaker of the Graduate Research Training Group "Molecular principles of synthetic biology" (GRK 2062)
  • 2010 - 2019 Research group leader at the Department of Chemistry, Technische Universität Munich, Germany
  • 2007 - 2010 Postdoctoral research fellow in the group of Prof. Dr. Thomas Carell, Ludwig- Maximilians University, Munich, Germany
  • 2004 - 2007 PhD thesis in the group of Dr. Max Paoli, University of Nottingham, United Kingdom and Griffith University Brisbane, Australia
  • 2002 - 2003 Work and Travel in Australia
  • 2001 - 2002 Diploma thesis in the group of Prof. Dr. Michael Stürzl, GSF Research Centre for Environment and Health, Neuherberg, Germany
  • 1996 - 2002 Diploma studies in Biology, Ludwig-Maximilians University, Munich, Germany

Key publications

  • Hoegl, A., Nodwell, M.B., Kirsch, V.C., Bach, N.C., Pfanzelt, M., Stahl, M., Schneider, S., Sieber, S.A. Mining the cellular inventory of pyridoxal phosphate-dependent enzymes with functionalized cofactor mimics. Nat. Chem. 2018, doi: 10.1038/s41557-018-0144-2
  • Willkomm S., Oellig, C. A., Zander, A., Restle, T., Keegan, R., Grohmann, D., Schneider, S. Structural and mechanistic insights into an archaeal DNA-guided Argonaute protein. Nat. Microbiol., 2017, doi: 10.1038/nmicrobiol.2017.35
  • Kirchner M., Schneider, S. Gene expression control by Bacillus anthracis purine riboswitches. RNA, 2017, 23, p. 762-9. doi: 10.1261/rna.058792.116.
  • Kirchner, M., Schorpp, K., Hadian, K., Schneider, S. An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system. Sci. Rep., 2017, 7: 7732; doi:10.1038/s41598-017-07870-w
  • Kläger, S., Heinzlmeir, S., Wilhelm, M., Helm, D. Qiao, H., Polzer, H., Vick, B., Reiter, K., Reinecke, M., Ruprecht, B., Petzoldt, S., Koch, H., Schoof, M., Canevari, G., Casale, E., Re Depaolini, S., Feuchtinger, A., Meng, C., Wu, Z., Zecha, J., Schmidt, T., Rückert., L, Becker, W., Hünges, J., Gohlke, B., Garz, A., König, P., Hahne, H., Ruland, J., Preissner, R., Götze, K., Kayser, G., Tönisson, N., Greif, P., Schlegl, J., Ehrlich, H., Aiche, S., Felder, E., Kramer, K., Schneider, S., Walch, A., Médard, G,. Jeremias, I., Spiekermann, K., Küster, B. The target landscape of clinical kinase drugs. Science, 2017, 358, eaan4368